Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd., along with CD3 and LICR at KU Leuven, announced that they have entered...
Laekna Therapeutics announced that the investigational new drug (IND) application of a combination therapy for the phase 1/2 clinical trial in patients with solid...
Optimvia, a biotechnology company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules, and Ginkgo Bioworks, the leading horizontal platform for...
REGENXBIO Inc. announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202,...
Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed that the NextGenPCR PCR reagents detected...
